Atricure to participate in the stifel 2023 healthcare conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming stifel 2023 healthcare conference. atricure's management is scheduled to participate in a fireside chat on tuesday, november 14, 2023, at 10:55 a.m. eastern standard time. interested parties may access a live audio w.
ATRC Ratings Summary
ATRC Quant Ranking